Search

everythinglearnresearchcommunity

for

Search:↓

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Low-dose isotretinoin is as effective as conventional doses for acne and has fewer side effects.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.